You are here:

bosentan (Tracleer)


In the absence of a submission from the holder of the marketing authorisation.

bosentan (Traceleer®), is not recommended for use within NHS Scotland for the treatment of pulmonary arterial hypertension (PAH) WHO functional class II.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.

Drug Details

Drug Name: bosentan (Tracleer)
SMC Drug ID: 523/08
Manufacturer: Actelion Pharmaceuticals UK Ltd
Indication: pulmonary arterial hypertension (PAH) WHO functional class II
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 November 2008

Archived Advice

Full submission 7 March 2003